Transgenic expression of Bcl-2 modulates energy metabolism, prevents cytosolic acidification during ischemia, and reduces ischemia/reperfusion injury - PubMed (original) (raw)
Transgenic expression of Bcl-2 modulates energy metabolism, prevents cytosolic acidification during ischemia, and reduces ischemia/reperfusion injury
Kenichi Imahashi et al. Circ Res. 2004.
Abstract
The antiapoptotic protein Bcl-2 is targeted to the mitochondria, but it is uncertain whether Bcl-2 affects only myocyte survival after ischemia, or whether it also affects metabolic functions of mitochondria during ischemia. Hearts from mice overexpressing human Bcl-2 and from their wild-type littermates (WT) were subjected to 24 minutes of global ischemia followed by reperfusion. During ischemia, the decrease in pH(i) and the initial rate of decline in ATP were significantly reduced in Bcl-2 hearts compared with WT hearts (P<0.05). The reduced acidification during ischemia was dependent on the activity of mitochondrial F1F0-ATPase. In the presence of oligomycin (Oligo), an F1F0-ATPase inhibitor, the decrease in pH(i) was attenuated in WT hearts, but in Bcl-2 hearts, Oligo had no additional effect on pH(i) during ischemia. Likewise, addition of Oligo to WT hearts slowed the rate of decline in ATP during ischemia to a level similar to that observed in Bcl-2 hearts, but addition of Oligo had no significant effect on the rate of decline in ATP in Bcl-2 hearts during ischemia. These data are consistent with Bcl-2-mediated inhibition of consumption of glycolytic ATP. Furthermore, mitochondria from Bcl-2 hearts have a reduced rate of consumption of ATP on uncoupler addition. This could be accomplished by limiting ATP entry into the mitochondria through the voltage-dependent anion channel, and/or the adenine nucleotide transporter, or by direct inhibition of the F1F0-ATPase. Immunoprecipitation showed greater interaction between Bcl-2 and voltage-dependent anion channel during ischemia. These data indicate that Bcl-2 modulation of metabolism contributes to cardioprotection.
Similar articles
- Glycogen synthase kinase 3 inhibition slows mitochondrial adenine nucleotide transport and regulates voltage-dependent anion channel phosphorylation.
Das S, Wong R, Rajapakse N, Murphy E, Steenbergen C. Das S, et al. Circ Res. 2008 Oct 24;103(9):983-91. doi: 10.1161/CIRCRESAHA.108.178970. Epub 2008 Sep 18. Circ Res. 2008. PMID: 18802025 Free PMC article. - Mechanisms of ischemic preconditioning in rat myocardium. Roles of adenosine, cellular energy state, and mitochondrial F1F0-ATPase.
Vuorinen K, Ylitalo K, Peuhkurinen K, Raatikainen P, Ala-Rämi A, Hassinen IE. Vuorinen K, et al. Circulation. 1995 Jun 1;91(11):2810-8. doi: 10.1161/01.cir.91.11.2810. Circulation. 1995. PMID: 7758188 - Effect of ischemic preconditioning on mitochondrial oxidative phosphorylation and high energy phosphates in rat hearts.
Kobara M, Tatsumi T, Matoba S, Yamahara Y, Nakagawa C, Ohta B, Matsumoto T, Inoue D, Asayama J, Nakagawa M. Kobara M, et al. J Mol Cell Cardiol. 1996 Feb;28(2):417-28. doi: 10.1006/jmcc.1996.0038. J Mol Cell Cardiol. 1996. PMID: 8729072 - Pharmacological profile of the selective mitochondrial F1F0 ATP hydrolase inhibitor BMS-199264 in myocardial ischemia.
Grover GJ, Malm J. Grover GJ, et al. Cardiovasc Ther. 2008 Winter;26(4):287-96. doi: 10.1111/j.1755-5922.2008.00065.x. Cardiovasc Ther. 2008. PMID: 19035880 Review. - ATPase activity, IF1 content, and proton conductivity of ESMP from control and ischemic slow and fast heart-rate hearts.
Rouslin W, Broge CW, Guerrieri F, Capozza G. Rouslin W, et al. J Bioenerg Biomembr. 1995 Aug;27(4):459-66. doi: 10.1007/BF02110008. J Bioenerg Biomembr. 1995. PMID: 8595981 Review.
Cited by
- Vagal nerve stimulation protects cardiac injury by attenuating mitochondrial dysfunction in a murine burn injury model.
Lu X, Costantini T, Lopez NE, Wolf PL, Hageny AM, Putnam J, Eliceiri B, Coimbra R. Lu X, et al. J Cell Mol Med. 2013 May;17(5):664-71. doi: 10.1111/jcmm.12049. Epub 2013 Apr 12. J Cell Mol Med. 2013. PMID: 23577721 Free PMC article. - MicroRNA-181c targets Bcl-2 and regulates mitochondrial morphology in myocardial cells.
Wang H, Li J, Chi H, Zhang F, Zhu X, Cai J, Yang X. Wang H, et al. J Cell Mol Med. 2015 Sep;19(9):2084-97. doi: 10.1111/jcmm.12563. Epub 2015 Apr 20. J Cell Mol Med. 2015. PMID: 25898913 Free PMC article. - Novel therapeutic strategies for ischemic heart disease.
Perricone AJ, Vander Heide RS. Perricone AJ, et al. Pharmacol Res. 2014 Nov;89:36-45. doi: 10.1016/j.phrs.2014.08.004. Epub 2014 Sep 1. Pharmacol Res. 2014. PMID: 25193582 Free PMC article. Review. - Heart mitochondrial proteome study elucidates changes in cardiac energy metabolism and antioxidant PRDX3 in human dilated cardiomyopathy.
Roselló-Lletí E, Tarazón E, Barderas MG, Ortega A, Otero M, Molina-Navarro MM, Lago F, González-Juanatey JR, Salvador A, Portolés M, Rivera M. Roselló-Lletí E, et al. PLoS One. 2014 Nov 14;9(11):e112971. doi: 10.1371/journal.pone.0112971. eCollection 2014. PLoS One. 2014. PMID: 25397948 Free PMC article. - Mechanisms of postischemic cardiac death and protection following myocardial injury.
Mastoor Y, Murphy E, Roman B. Mastoor Y, et al. J Clin Invest. 2025 Jan 2;135(1):e184134. doi: 10.1172/JCI184134. J Clin Invest. 2025. PMID: 39744953 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases